Floatz logo

zx008

Lennox Gastaut Syndrome

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.Phase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Lennox Gastaut Syndrome cohort.

Asset / SponsorPhaseRating
gwp42003-p
Jazz Pharmaceuticals
Phase 4BBB
Rufinamide
Eisai Co., Ltd.
Phase 3BB
Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)-
University of Chicago
Phase 3BB
Bexicaserin
Longboard Pharmaceuticals
Phase 2BB
MELATONIN
Institution de Lavigny
Phase 4BB

View all 14 →

Same molecule, other indications

zx008 is also rated in:

Dravet syndromeDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →